Evidence map›Paper›PMID 42786269›Full record

ArticleOncogene2026

Synonymous codon usage shapes ERα function through specialized translational programs during breast cancer progression.

Tamara Fernandez-Calero, Raphaël Métivier, Frederic Percevault, Léa Clusan, Mewen Briend, Charly Jehanno, Cyrille Garnier, Coralie Fontaine, Emmanuel Guidice, Reynald Gillet and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tamara Fernandez-Calero *Departamento de Biociencias, Universidad Católica del Uruguay, Montevideo, Uruguay.ORCID http://orcid.org/0000-0001-7857-4635
Raphaël Métivier *Univ Rennes, Institut de Génétique et de développement de Rennes (IGDR), UMR 6290 CNRS-Université de Rennes, ERL INSERM U1305. CS 74205- 35042, Rennes, France.
Frederic PercevaultUniv Rennes, Inserm, EHESP, Irset, Institut de Recherche en Santé Environnement et Travail - UMR_S 1085, Rennes, France.
Léa ClusanUniv Rennes, Inserm, EHESP, Irset, Institut de Recherche en Santé Environnement et Travail - UMR_S 1085, Rennes, France.
Mewen BriendUniv Rennes, Inserm, EHESP, Irset, Institut de Recherche en Santé Environnement et Travail - UMR_S 1085, Rennes, France.ORCID http://orcid.org/0000-0002-0646-1436
Charly JehannoDepartment of Biomedicine, University of Basel, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-2897-6027
Cyrille GarnierUniv Rennes, Inserm, EHESP, Irset, Institut de Recherche en Santé Environnement et Travail - UMR_S 1085, Rennes, France.ORCID http://orcid.org/0000-0002-5715-8218
Coralie FontaineINSERM U1048, Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse - UPS, Toulouse, France.
Emmanuel GuidiceUniv Rennes, Institut de Génétique et de développement de Rennes (IGDR), UMR 6290 CNRS-Université de Rennes, ERL INSERM U1305. CS 74205- 35042, Rennes, France.
Reynald GilletUniv Rennes, Institut de Génétique et de développement de Rennes (IGDR), UMR 6290 CNRS-Université de Rennes, ERL INSERM U1305. CS 74205- 35042, Rennes, France.
Hugo NayaBioinformatics Unit, Institut Pasteur Montevideo, Montevideo, Uruguay.
Jean-François ArnalINSERM U1048, Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse - UPS, Toulouse, France.
Monica MarinBiochemistry-Molecular Biology, Facultad de Ciencias, Universidad de la República, Iguá, Montevideo, Uruguay.
Denis MichelUniv Rennes, Inserm, EHESP, Irset, Institut de Recherche en Santé Environnement et Travail - UMR_S 1085, Rennes, France.ORCID http://orcid.org/0000-0002-0643-8025
Gilles FlouriotUniv Rennes, Inserm, EHESP, Irset, Institut de Recherche en Santé Environnement et Travail - UMR_S 1085, Rennes, France. gilles.flouriot@univ-rennes1.fr.ORCID http://orcid.org/0000-0001-6250-4173

Funding

Ligue Contre le Cancer No grant reference number
6 · The paper itself

Abstract

Long considered neutral, synonymous codon usage is increasingly recognized as a regulatory layer of mRNA translation. Proteins expressed during proliferation are translated from mRNAs with codon compositions distinct from those encoding proteins in differentiated states, suggesting the existence of specialized translational programs. In hormone-receptor-positive breast cancer, estrogen receptor-alpha (ERα/ESR1) acts both as a driver of proliferation and as a maintainer of luminal identity, making its translational regulation particularly relevant. Here, we show that the transition of breast cancer cells from quiescent, differentiated states towards proliferative, less differentiated phenotypes, is accompanied by a systematic shift from G/C3- to A/U3-biased codon usage. ERα coding sequence architecture mirrors these translational programs through both global codon composition and position-dependent codon patterns. These features influence translational efficiency and likely modulate co-translational folding dynamics, thereby adjusting receptor abundance and functional outputs according to the prevailing translational program. Consistent with their functional importance, synonymous codon choices are subject to increased selective constraints within regions encoding structural and functional domains. Using engineer synonymous ERα variants, we demonstrate that codon usage fine-tunes receptor function across distinct cellular states. Together, our findings identify synonymous codon usage as a previously unrecognized mechanism linking translational programs to ERα expression and function.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.